{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:26:57Z","timestamp":1760059617523,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Fetuin-A is mostly synthesized in the liver. It is a hepatokine, which is an extracellular inhibitor of growth factors. There is a scarcity of data on the clinical utility of serum fetuin-A (SFA) in alcohol-associated cirrhosis (AC). We first investigated the association between SFA levels and disease phenotypes in alcoholic liver disease (ALD) patients, including alcohol-associated steatotic liver (ASL) and alcohol-associated hepatitis (AH), along with AC patients. Materials and Methods: There were 26 healthy controls and 64 ALD patients in this case\u2013control study. The severity of the disease in the AC patients was evaluated using the Child\u2013Pugh classification (CPC-A, -B, and -C), and the FH and AC patients\u2019 Maddrey\u2019s differential function scores and the Model of End-Stage Liver Disease Sodium (MELD-Na) scores were computed. We measured SFA levels using a human fetuin-A enzyme-linked immunosorbent assay (ELISA) kit. Results: The SFA concentrations were lower in the AC group and higher in the ASL group [670.72 (412.36) mg\/L vs. 1484.61 (858.16) mg\/L, respectively; p &lt; 0.001]. When compared to patients with ASL, the SFA levels in AC patients were noticeably lower. However, similar SFA levels were observed for the AH group and the healthy controls, as well as for the ASL group and the healthy controls. Within the AC group, the CPC-A subgroup had the highest median SFA values, while the CPC-C subgroup had the lowest median SFA value. Furthermore, the median SFA levels demonstrated significant and inverse correlations with the CPC scores and the MELD-Na scores (rho = \u22120.671, p &lt; 0.001; rho = \u22120.742, p &lt; 0.001, respectively). A negative correlation was observed between the SFA levels and the MELD-Na scores in the AH group (\u03c1 = \u22120.621, p = 0.013). Conclusions: In ALD patients, decreased SFA levels, which exhibit disease severity, might be an auxiliary biomarker for the follow-up of AC patients.<\/jats:p>","DOI":"10.3390\/medicina61071147","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T08:23:22Z","timestamp":1750839802000},"page":"1147","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fetuin-A Can Assess the Severity of Alcohol-Related Liver Disease"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-531X","authenticated-orcid":false,"given":"Musa","family":"Salmano\u011flu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sultan 2. Abdulhamid Han Training and Research Hospital, University of Health Sciences, Istanbul 34668, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7449-8276","authenticated-orcid":false,"given":"\u0130rfan","family":"K\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kartal Dr. L\u00fctfi K\u0131rdar City Hospital, University of Health Sciences, \u0130stanbul 34865, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-445X","authenticated-orcid":false,"given":"S\u00fcleyman","family":"Ba\u015f","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.alcohol.2019.05.004","article-title":"Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium","volume":"83","author":"Kirpich","year":"2020","journal-title":"Alcohol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e176345","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxrep.2021.02.010","article-title":"Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy","volume":"8","author":"Subramaniyan","year":"2021","journal-title":"Toxicol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2478\/jtim-2019-0029","article-title":"Role of Hepatokines in Non-alcoholic Fatty Liver Disease","volume":"7","author":"Ke","year":"2019","journal-title":"J. Transl. Int. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2265.2012.04460.x","article-title":"Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"78","author":"Dogru","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","article-title":"Cloning and targeted deletion of the mouse fetuin gene","volume":"272","author":"Schinke","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Etienne, Q., Lebrun, V., Komuta, M., Navez, B., Thissen, J.P., Leclercq, I.A., and Lanthier, N. (2022). Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis. Metabolites, 12.","DOI":"10.3390\/metabo12070625"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0168-8278(97)80483-7","article-title":"Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis","volume":"26","author":"Kalabay","year":"1997","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00042737-200204000-00009","article-title":"Human fetuin\/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer","volume":"14","author":"Kalabay","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_10","unstructured":"Chen, T.M. (2005). Human fetuin\/\u03b12HS-glycoprotein levels in sera of patients with liver disease. Liver Cirrhosis: New Research, Nova Science."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/intimm\/dxh024","article-title":"Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b","volume":"16","author":"Kalabay","year":"2004","journal-title":"Int. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/CIRCULATIONAHA.111.072751","article-title":"Association of fetuin-a with incident diabetes mellitus in community-living older adults: The cardiovascular health study","volume":"125","author":"Ix","year":"2012","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.11.004","article-title":"Effects of fetuin-A with diverse functions and multiple mechanisms on human health","volume":"88","author":"Icer","year":"2021","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00125-013-3077-8","article-title":"Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women","volume":"57","author":"Ley","year":"2014","journal-title":"Diabetologia"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kalabay, L., Gr\u00e1f, L., V\u00f6r\u00f6s, K., Jakab, L., Benko, Z., Telegdy, L., Fekete, B., Proh\u00e1szka, Z., and F\u00fcst, G. (2007). Human serum fetuin A\/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores. BMC Gastroenterol., 7.","DOI":"10.1186\/1471-230X-7-15"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3892\/etm.2016.3754","article-title":"Concentrations of fetuin-A, osteoprotegerin and \u03b1-Klotho in patients with alcoholic liver cirrhosis","volume":"12","author":"Prystupa","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/NMD.0b013e3182a2168a","article-title":"Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility","volume":"201","author":"First","year":"2013","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1053\/j.gastro.2011.02.017","article-title":"A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation","volume":"140","author":"Leise","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gonzalez-Cantero, J., Martin-Rodriguez, J.L., Gonzalez-Cantero, A., Arrebola, J.P., and Gonzalez-Calvin, J.L. (2018). Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192663"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0009-8981(88)90173-8","article-title":"Modifications of concanavalin A patterns of alpha 1-acid glycoprotein and alpha 2-HS glycoprotein in alcoholic liver disease","volume":"176","author":"Jezequel","year":"1988","journal-title":"Clin. Chim. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691.x","article-title":"Systematic review: The model for end-stage liver disease--should it replace Child-Pugh\u2019s classification for assessing prognosis in cirrhosis?","volume":"22","author":"Cholongitas","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1002\/cncr.29577","article-title":"Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index","volume":"121","author":"Suh","year":"2015","journal-title":"Cancer"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1147\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:58:27Z","timestamp":1760032707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071147"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071147","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}